-
-
Overview
-
Please contact us at for specific academic pricing.
Background
Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1. Phase 4.
-
- Properties
-
Overview